"Doxycycline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic tetracycline derivative with similar antimicrobial activity.
| Descriptor ID |
D004318
|
| MeSH Number(s) |
D02.455.426.559.847.562.900.200 D04.615.562.900.200
|
| Concept/Terms |
Doxycycline- Doxycycline
- Alpha-6-Deoxyoxytetracycline
- Alpha 6 Deoxyoxytetracycline
- Doxycycline Monohydrate
Doxycycline Hyclate- Doxycycline Hyclate
- Hyclate, Doxycycline
- Doxycycline Hemiethanolate
- Hemiethanolate, Doxycycline
|
Below are MeSH descriptors whose meaning is more general than "Doxycycline".
Below are MeSH descriptors whose meaning is more specific than "Doxycycline".
This graph shows the total number of publications written about "Doxycycline" by people in this website by year, and whether "Doxycycline" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 10 | 25 | 35 |
| 2018 | 6 | 22 | 28 |
| 2019 | 3 | 5 | 8 |
| 2020 | 4 | 2 | 6 |
| 2021 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Doxycycline" by people in Profiles.
-
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic. Expert Rev Proteomics. 2021 08; 18(8):707-717.
-
Frequency of COVID-19 in acne patients treated with oral doxycycline: A retrospective cross-sectional comparative study. J Cosmet Dermatol. 2021 Oct; 20(10):3062-3063.
-
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet Respir Med. 2021 09; 9(9):1010-1020.
-
A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status. Biomed Pharmacother. 2021 Oct; 142:111956.
-
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial. J Int Med Res. 2021 May; 49(5):3000605211013550.
-
Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review. Drug Saf. 2021 06; 44(6):635-644.
-
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects. Pulm Pharmacol Ther. 2021 04; 67:102008.
-
Tetracycline as an inhibitor to the SARS-CoV-2. J Cell Biochem. 2021 07; 122(7):752-759.
-
Multidrug treatment for COVID-19. Drug Discov Ther. 2021 Mar 10; 15(1):39-41.
-
Case Report: Limitations of Virtual Care in Older Adults with Functional and Cognitive Impairment. Am Fam Physician. 2021 02 15; 103(4):201.